Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines

Mehmet Rıfkı Topçul

doi:10.17776/csj.511141

TR EN

Baicalein’in Farklı Meme Kanseri Hücre hatlarındaki Kinetik Etkilerinin Değerlendirilmesi

Abstract

Bu çalışmada, bir flavonoid olan baicalein’in MCF-7 ve MDA-MB-231 hücre hatları üzerinde meydana getireceği antiproliferatif etkilerin karşılaştırılması amaçlanmıştır. Hücre canlılığı, hücre indeksi, mitotik indeks, işaretlenme indeksi ve apoptotik indeks gibi hücre kinetiği parametrelerinin değerlendirilmesi ile deneyler gerçekleştirilmiştir.

Yapılan hücre canlılığı testi ile baicalein’in MCF-7 ve MDA-MB-231 hücreleri için IC₅₀ konsantrasyonları sırasıyla 10 µM ve 30 µM olarak belirlenmiş ve tüm deneylerde bu konsantrasyonlar kullanılmıştır. Elde edilen sonuçlar kullanılan IC₅₀ konsantrasyonların her hücre tipi için de hücre canlılığı, hücre indeksi, mitotik indeks ve işaretlenme indeksi değerlerini azaltırken apoptotik indeks değerini yükselttiğini göstermiştir. Bu azalma ve artışlar istatistiksel olarak anlamlıdır (p<0.01). Ayrıca xCelligence Gerçek Zamanlı Hücre Analiz Sisteminden elde edilen grafiklere ait eğriler, baicalein’in MCF-7 hücrelerinde sitoskeletal etkiler meydana getirirken MDA-MB-231 hücrelerinde sitostatik etki meydana getirdiğini göstermiştir. Bu çalışmadan elde edilen sonuçlar baicalein’in MCF-7 ve MDA-MB-231 hücreleri üzerine antiproliferatif etkilerinden dolayı ileride yapılacak çalışmalarla desteklenerek, klinikte luminal A ve üçlü negatif meme kanseri hastaları için de kullanılabileceğini düşündürmektedir.

Keywords

Baicalein,Luminal A meme kanseri,Üçlü negatif meme kanseri

Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines

Abstract

The aim of this study was to compare the antiproliferative effects of baicalein which is a flavonoide on MCF-7 and MDA-MB-231 cell line. The experiments were carried out with the evaluation of the parameters. Including cell viability, cell index, mitotic index, labelling index and apoptotic index. With the cell viability test, IC₅₀ concentrations of baicalein for MCF-7 and MDA-MB-231 cells were determined as 10 µM and 30 µM, respectively and these concentrations were used in all experiments. The results showed that the IC₅₀ concentrations decreased the values of cell viability, cell index, mitotic index and labelling index and increased the apoptotic index value for both cell types. These decreases and increases are statistically significant (p<0.01). In addition, curves of the graphs obtained from the xCelligence Real-Time Cell Analysis System showed that baicalein has cytoskeletal effects on MCF-7 cells and cytostatic effects on MDA-MB-231 cells. The results obtained from this study suggest that baicalein can be used in patients with luminal A and triple negative breast cancer in the clinic by supporting the future studies due to its antiproliferative effects on MCF-7 and MDA-MB-231 cells.

Keywords

Baicalein,Luminal A breast cancer,Triple negative breast cancer

References

[1]. Xie HY, Shao ZM and Li DQ., Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J. Cancer, 36 (2017) 36.
[2]. Siegel RL, Miller KD and Jemal A., Cancer statistics, 2016. C.A. Cancer J Clin., 66 (2016) 7-30.
[3]. Çetin İ, Topçul MR., Triple Negative Breast Cancer, APJCP. 15 (2014) 2427-243.
[4]. Di Carlo G, Mascolo N, Izzo AA, Capasso F., Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci., 65 (1999) 337-353.
[5]. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD., Flavonoids activate wild-type p53. Oncogene, 13 (1996) 1605-1614.
[6]. Naasani I, Oh-Hashi F, Oh-Hara T, et al., Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer, 63 (2003) 824-830.
[7]. Kobayashi T, Nakata T, Kuzumaki T., Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett., 176 (2002) 17-23.
[8]. Bonham M, Posakony J, Coleman I, Montgomery B, Simon J, Nelson PS., Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res., 11 (2005) 3905-3914.
[9]. Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH., In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J. Oncol., 26 (2005) 241-246. [10]. Ma Z, Otsuyama K, Liu S, et al., Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood, 105 (2005) 3312- 3318.
[11]. Lee HZ, Leung HWC, Lai MY, Wu CH., Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res. 25 (2005) 959-964.

[12]. Chao JI, Su WC, Liu HF., Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol Cancer Ther., 6 (2007) 3039-3048.
[13]. Chen Z, Hou R, Gao S, Song D, Feng Y., Baicalein inhibits proliferation activity of human colorectal cancer cells HCT116 through downregulation of ezrin. Cell Physiol Biochem., 49 (2018) 2035-2046.
[14]. Mu J, Liu T, Jiang L, Wu X, Cao Y, Li M, Dong Q, Liu Y, Xu H., The Traditional Chinese medicine baicalein potently inhibits gastric cancer cells. Journal of Cancer, 7 (2016) 453-461.
[15]. Lin CW, Yang LY, Shen SC and Chen YC., IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells. J Cell Physiol., 2012 (2007) 666-674.
[16]. Branham WS, Dial SL, Moland CL, Hass BS, Blair RM, Fang H, Shi L, Tong W, Perkins RG and Sheehan DM., Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr., 132 (2002) 658-664.
[17]. Shenouda NS, Zhou C, Browning JD, Ansell PJ, Sakla MS, Lubahn DB and Macdonald RS., Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer, 49 (2004) 200-208.
[18]. Po LS, Chen ZY, Tsang DS, Leung LK., Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett., 187 (2002) 33-40.
[19]. An H, Yu X, Xiang C, Zhang Y, Xia J, Wang Y., Original Article Baicalein and U0126 suppress human breast cancer cell line MCF-7 through regulating MAPK signaling pathway. Int J Clin Exp Pathol., 9 (2016) 10266-10273.
[20]. Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S., Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Design, Development and Therapy, 10 (2016) 1419-1441.

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Authors

Mehmet Rıfkı Topçul ^*
0000-0002-9685-9404
Türkiye

Publication Date

March 22, 2019

Submission Date

January 10, 2019

Acceptance Date

February 25, 2019

Published in Issue

Year 2019 Volume: 40 Number: 1

DOI

https://doi.org/10.17776/csj.511141

IZ

https://izlik.org/JA25FL26MN

APA

Topçul, M. R. (2019). Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines. Cumhuriyet Science Journal, 40(1), 150-157. https://doi.org/10.17776/csj.511141

AMA

1.Topçul MR. Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines. CSJ. 2019;40(1):150-157. doi:10.17776/csj.511141

Chicago

Topçul, Mehmet Rıfkı. 2019. “Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines”. Cumhuriyet Science Journal 40 (1): 150-57. https://doi.org/10.17776/csj.511141.

EndNote

Topçul MR (March 1, 2019) Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines. Cumhuriyet Science Journal 40 1 150–157.

IEEE

[1]M. R. Topçul, “Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines”, CSJ, vol. 40, no. 1, pp. 150–157, Mar. 2019, doi: 10.17776/csj.511141.

ISNAD

Topçul, Mehmet Rıfkı. “Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines”. Cumhuriyet Science Journal 40/1 (March 1, 2019): 150-157. https://doi.org/10.17776/csj.511141.

JAMA

1.Topçul MR. Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines. CSJ. 2019;40:150–157.

MLA

Topçul, Mehmet Rıfkı. “Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines”. Cumhuriyet Science Journal, vol. 40, no. 1, Mar. 2019, pp. 150-7, doi:10.17776/csj.511141.

Vancouver

1.Mehmet Rıfkı Topçul. Evaluation of Kinetic Effects of Baicalein in Different Breast Cancer Cell Lines. CSJ. 2019 Mar. 1;40(1):150-7. doi:10.17776/csj.511141

Cited By

In silico study of baicalin as an inhibitor of HER-2 receptor in breast cancer

Pharmacy Reports

https://doi.org/10.51511/pr.26

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December